Lipoprotein apheresis influences monocyte subpopulations

Atherosclerosis Supplements - Tập 30 - Trang 108-114 - 2017
S. Jellinghaus1, C. Reich1, U. Schatz2, S. Tselmin2, K. Ibrahim1, C. Pfluecke1, A. Schauer1, S.R. Bornstein2, B. Hohenstein2, R.H. Strasser1, U. Julius2, D.M. Poitz1
1Internal Medicine and Cardiology, Heart Center Dresden, University Hospital at the Technische Universität, Dresden, Germany
2Department of Internal Medicine III, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany

Tài liệu tham khảo

Shi, 2011, Monocyte recruitment during infection and inflammation, Nat Rev Immunol, 11, 762, 10.1038/nri3070 Yang, 2014, Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases, Biomark Res, 2, 1, 10.1186/2050-7771-2-1 Mukherjee, 2015, Non-classical monocytes display inflammatory features: validation in sepsis and systemic lupus erythematous, Sci Rep, 5, 13886, 10.1038/srep13886 Ziegler-Heitbrock, 2007, The CD14+ CD16+ blood monocytes: their role in infection and inflammation, J Leukoc Biol, 81, 584, 10.1189/jlb.0806510 Idzkowska, 2015, The role of different monocyte subsets in the pathogenesis of atherosclerosis and acute coronary syndromes, Scand J Immunol, 82, 163, 10.1111/sji.12314 Auffray, 2007, Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior, Science, 317, 666, 10.1126/science.1142883 Rogacev, 2012, CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography, J Am Coll Cardiol, 60, 1512, 10.1016/j.jacc.2012.07.019 Schlitt, 2004, CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels, Thromb Haemost, 92, 419, 10.1160/TH04-02-0095 Rothe, 1999, A more mature phenotype of blood mononuclear phagocytes is induced by fluvastatin treatment in hypercholesterolemic patients with coronary heart disease, Atherosclerosis, 144, 251, 10.1016/S0021-9150(99)00061-1 Libby, 2002, Inflammation in atherosclerosis, Nature, 420, 868, 10.1038/nature01323 Stefanutti, 2013, Lipoprotein apheresis: state of the art and novelties, Atheroscler Suppl, 14, 19, 10.1016/j.atherosclerosissup.2012.10.021 Bhoj, 2015, Lipoprotein apheresis, Curr Atheroscler Rep, 17, 39, 10.1007/s11883-015-0516-7 Julius, 2013, Lipoprotein apheresis: an update, Clin Lipidol, 8, 693, 10.2217/clp.13.68 Ross, 1999, Atherosclerosis is an inflammatory disease, Am Heart J, 138, S419, 10.1016/S0002-8703(99)70266-8 Kashiwagi, 2010, Association of monocyte subsets with vulnerability characteristics of coronary plaques as assessed by 64-slice multidetector computed tomography in patients with stable angina pectoris, Atherosclerosis, 212, 171, 10.1016/j.atherosclerosis.2010.05.004 Rothe, 1996, Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia, Arterioscler Thromb Vasc Biol, 16, 1437, 10.1161/01.ATV.16.12.1437 Catapano, 2016, Eur Heart J, 37, 2999, 10.1093/eurheartj/ehw272 Krychtiuk, 2015, Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein(a), J Clin Lipidol, 9, 533, 10.1016/j.jacl.2015.04.005 Tsujioka, 2009, Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction, J Am Coll Cardiol, 54, 130, 10.1016/j.jacc.2009.04.021 Thomas, 2015, Nonclassical patrolling monocyte function in the vasculature, Arterioscler Thromb Vasc Biol, 35, 1306, 10.1161/ATVBAHA.114.304650 Weiss, 2017, Release and cellular origin of extracellular vesicles during circulation of whole blood over adsorbent polymers for lipid apheresis, J Biomed Mater Res B Appl Biomater, 105, 636, 10.1002/jbm.b.33588 Kopprasch, 2009, Beyond lowering circulating LDL: apheresis-induced changes of systemic oxidative stress markers by four different techniques, Atheroscler, 34, 10.1016/S1567-5688(09)71807-0 Grassler, 2013, Differential effects of lipoprotein apheresis by lipidfiltration or dextran sulfate adsorption on lipidomic profile, Atheroscler, 151, 10.1016/j.atherosclerosissup.2012.10.006 Hovland, 2012, Complement profile and activation mechanisms by different LDL apheresis systems, Acta Biomater, 8, 2288, 10.1016/j.actbio.2012.02.017 Kobayashi, 2006, LDL-apheresis reduces P-Selectin, CRP and fibrinogen – possible important implications for improving atherosclerosis, Ther Apher Dial, 10, 219, 10.1111/j.1744-9987.2006.00332.x Cattin, 1997, Low density lipoprotein-apheresis decreases oxidized low density lipoproteins and monocyte adhesion to endothelial cells, ASAIO J, 43, 209 Morawietz, 2013, Lipoprotein apheresis of hypercholesterolemic patients mediates vasoprotective gene expression in human endothelial cells, Atheroscler Suppl, 14, 107, 10.1016/j.atherosclerosissup.2012.10.013